Hello, Fool! | Login | Signup | My Fool
Jan 8, 2009 8:10 AM ET | Feedback | Site Changes | Help
The Company operates business in three reporting segments: Molecular Services, Clinics and Small Hospitals and All Other.
View All Commentary (CLDA)
Recs
spitfire1980fan (67.66) Submitted: 10/04/07 7:54 AM : Start Price: $25.40 CLDA Score: -24.54
Great management and growing in the right direction in the area of personalized medicine. The FDA is looking for companies like this to make medicine safer for everyone (recent warfarin lable change), they will do everything they can to work with CLDA through the processes of new drugs/tests as they both want the same thing......safer drugs with less side effects. A true pure play in personalized medicine here.............It's the future folks.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.